This inventor holds 1 USPTO granted patent. Top assignees: Changzhou Yabang Pharmaceutical Co., Ltd, Jiangsu Yabang Shengyuan Pharmaceutical Co., Ltd, Yabang Pharmaceutical Co., Ltd. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovations of Ming-Guang Zhang
Introduction
Ming-Guang Zhang is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial agents. His work has led to the creation of innovative compounds that have potential applications in medicine.
Latest Patents
Ming-Guang Zhang holds a patent for a compound known as 1,3-oxazolidine-2-one-like compound, along with its preparation method and uses. This invention provides 1,3-oxazolidin-2-one compounds of formula I and their salts, which are utilized in the preparation of linezolid racemate and its optical isomer. These compounds serve as oxazolidinone antibacterial agents, showcasing their importance in combating bacterial infections.
Career Highlights
Throughout his career, Ming-Guang Zhang has worked with prominent pharmaceutical companies, including Jiangsu Yabang Shengyuan Pharmaceutical Co., Ltd and Changzhou Yabang Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to the advancement of pharmaceutical innovations.
Collaborations
Ming-Guang Zhang has collaborated with esteemed colleagues such as Zai-Xin Chen and Yong Deng. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceuticals.
Conclusion
Ming-Guang Zhang's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to impact the development of effective antibacterial agents, showcasing the importance of innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile